Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -73.89% is 42% above its 5-year average of -128.36%, near the high end of its 5-year range (-557.31%–-9.53%).
20.79% below its 12-month average of -61.17%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -23.49%.
RETURN ON ASSETS (ROA)
-73.89%
RETURN ON ASSETS (ROA) AVG TTM
-61.17%
RETURN ON ASSETS (ROA) AVG 3Y
-50.83%
RETURN ON ASSETS (ROA) AVG 5Y
-128.36%
RETURN ON ASSETS (ROA) AVG 10Y
-158.53%
RETURN ON ASSETS (ROA) AVG 15Y
-176.50%
RETURN ON ASSETS (ROA) AVG 20Y
-396.66%
CURRENT VS TTM AVG
-20.79%
CURRENT VS 3Y AVG
-45.36%
CURRENT VS 5Y AVG
+42.44%
CURRENT VS 10Y AVG
+53.39%
CURRENT VS 15Y AVG
+58.14%
CURRENT VS 20Y AVG
+81.37%
SECTOR MEDIAN · HEALTHCARE
-30.70%
median of 713 covered companies
CURRENT VS SECTOR MEDIAN
-140.68%
vs the sector median at left
Ainos, Inc.
Market Cap
$9.79M
Return on Assets (ROA)
-73.89%
TTM Avg
-61.17%
3Y Avg
-50.83%
5Y Avg
-128.36%
Market Cap
$9.71M
Return on Assets (ROA)
-108.85%
TTM Avg
-94.23%
3Y Avg
-71.21%
5Y Avg
-107.74%
Market Cap
$10.01M
Return on Assets (ROA)
-115.57%
TTM Avg
-131.41%
3Y Avg
-121.81%
5Y Avg
-149.86%
Market Cap
$10.06M
Return on Assets (ROA)
-204.84%
TTM Avg
-224.84%
3Y Avg
-332.29%
5Y Avg
-789.37%
Market Cap
$9.34M
Return on Assets (ROA)
-269.20%
TTM Avg
-150.53%
3Y Avg
-111.73%
5Y Avg
-102.54%
Market Cap
$10.36M
Return on Assets (ROA)
-404.58%
TTM Avg
-269.82%
3Y Avg
-269.82%
5Y Avg
-269.82%
Market Cap
$10.43M
Return on Assets (ROA)
-52.23%
TTM Avg
-58.24%
3Y Avg
-82.00%
5Y Avg
-104.09%
Market Cap
$9.22M
Return on Assets (ROA)
-6.36%
TTM Avg
-31.97%
3Y Avg
-31.64%
5Y Avg
-61.82%
Market Cap
$10.52M
Return on Assets (ROA)
N/A
TTM Avg
-37.02%
3Y Avg
-41.41%
5Y Avg
-41.74%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ainos, Inc. (AIMD) | $9.79M | -73.89% | -61.17% | -50.83% | -128.36% |
| MetaVia Inc. (MTVA)vs › | $9.71M | -108.85% | -94.23% | -71.21% | -107.74% |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $10.01M | -115.57% | -131.41% | -121.81% | -149.86% |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.06M | -204.84% | -224.84% | -332.29% | -789.37% |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.34M | -269.20% | -150.53% | -111.73% | -102.54% |
| Caring Brands, Inc. (CABR)vs › | $10.36M | -404.58% | -269.82% | -269.82% | -269.82% |
| Satellos Bioscience Inc. (MSLE)vs › | $10.43M | -52.23% | -58.24% | -82.00% | -104.09% |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.22M | -6.36% | -31.97% | -31.64% | -61.82% |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.52M | N/A | -37.02% | -41.41% | -41.74% |
| Polyrizon Ltd. (PLRZ)vs › | $10.53M | N/A | -21.71% | -73.35% | -116.85% |
ROA
-73.9%
ROE
-440.1%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -70.77% |
| 2024-12-31 | -51.57% |
| 2023-12-31 | -43.25% |
| 2022-12-31 | -37.74% |
| 2021-12-31 | -9.53% |
| 2020-12-31 | -557.31% |
| 2019-12-31 | -265.19% |
| 2018-12-31 | -91.46% |
| 2017-12-31 | -26.91% |
| 2016-12-31 | -144.81% |
| 2015-12-31 | -445.30% |
| 2014-12-31 | -147.70% |
| 2013-12-31 | -385.44% |
| 2012-12-31 | -565.78% |
| 2011-12-31 | -1142.36% |
| 2010-12-31 | 195.22% |
| 2009-12-31 | -1243.55% |
| 2008-12-31 | -1201.40% |
| 2007-12-31 | -1171.64% |
| 2006-12-31 | -711.46% |
| 2005-12-31 | -211.89% |
| 2004-12-31 | -427.62% |
| 2003-12-31 | 95.49% |
| 2002-12-31 | -285.42% |
| 2001-12-31 | -126.37% |
| 2000-12-31 | -527.33% |
| 1999-12-31 | -391.61% |
| 1998-12-31 | -46.79% |
| 1997-12-31 | -34.09% |
| 1996-12-31 | -16.92% |
